Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Q32 Bio (QTTB) Cash from Financing Activities (2017 - 2025)

Q32 Bio (QTTB) has 9 years of Cash from Financing Activities data on record, last reported at -$1.6 million in Q4 2025.

  • For Q4 2025, Cash from Financing Activities fell 592.74% year-over-year to -$1.6 million; the TTM value through Dec 2025 reached -$1.8 million, down 101.9%, while the annual FY2025 figure was -$3.1 million, 103.28% down from the prior year.
  • Cash from Financing Activities reached -$1.6 million in Q4 2025 per QTTB's latest filing, roughly flat from -$1.6 million in the prior quarter.
  • Across five years, Cash from Financing Activities topped out at $99.3 million in Q1 2024 and bottomed at -$5.5 million in Q2 2024.
  • Average Cash from Financing Activities over 5 years is $8.5 million, with a median of $124000.0 recorded in 2022.
  • The widest YoY moves for Cash from Financing Activities: up 662206.67% in 2024, down 36913.33% in 2024.
  • A 5-year view of Cash from Financing Activities shows it stood at $1000.0 in 2021, then soared by 3100.0% to $32000.0 in 2022, then surged by 137.5% to $76000.0 in 2023, then surged by 317.11% to $317000.0 in 2024, then tumbled by 592.74% to -$1.6 million in 2025.
  • Per Business Quant database, its latest 3 readings for Cash from Financing Activities were -$1.6 million in Q4 2025, -$1.6 million in Q3 2025, and $317000.0 in Q4 2024.